Lifespan Cancer Institute, Rhode Island Hospital

Providence, Rhode Island 02903

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non Small Cell Lung Cancer, Cancer Harboring BRAF Alterations, Fallopian Tube Neoplasms, HGG, LGG, Metastatic Non Small Cell Lung Cancer, Ovarian Neoplasms, Peritoneal Neoplasms, Solid Tumors

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling
• Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. — Completed